nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—systemic scleroderma	0.88	1	CbGaD
Sodium stibogluconate—Hypotension—Captopril—systemic scleroderma	0.00021	0.00175	CcSEcCtD
Sodium stibogluconate—Pruritus—Pentoxifylline—systemic scleroderma	0.00021	0.00175	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00021	0.00174	CcSEcCtD
Sodium stibogluconate—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000205	0.0017	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000203	0.00169	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Mometasone—systemic scleroderma	0.000203	0.00168	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Mometasone—systemic scleroderma	0.000203	0.00168	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Captopril—systemic scleroderma	0.000202	0.00168	CcSEcCtD
Sodium stibogluconate—Palpitations—Leflunomide—systemic scleroderma	0.000201	0.00167	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Captopril—systemic scleroderma	0.000201	0.00167	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Lisinopril—systemic scleroderma	0.000201	0.00166	CcSEcCtD
Sodium stibogluconate—Dizziness—Pentoxifylline—systemic scleroderma	0.000197	0.00163	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Captopril—systemic scleroderma	0.000196	0.00163	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000196	0.00162	CcSEcCtD
Sodium stibogluconate—Infection—Azathioprine—systemic scleroderma	0.000195	0.00162	CcSEcCtD
Sodium stibogluconate—Syncope—Mycophenolic acid—systemic scleroderma	0.000195	0.00162	CcSEcCtD
Sodium stibogluconate—Fatigue—Captopril—systemic scleroderma	0.000194	0.00161	CcSEcCtD
Sodium stibogluconate—Chest pain—Leflunomide—systemic scleroderma	0.000194	0.00161	CcSEcCtD
Sodium stibogluconate—Anxiety—Leflunomide—systemic scleroderma	0.000193	0.0016	CcSEcCtD
Sodium stibogluconate—Constipation—Captopril—systemic scleroderma	0.000193	0.0016	CcSEcCtD
Sodium stibogluconate—Flatulence—Lisinopril—systemic scleroderma	0.000193	0.0016	CcSEcCtD
Sodium stibogluconate—Sepsis—Methotrexate—systemic scleroderma	0.000193	0.0016	CcSEcCtD
Sodium stibogluconate—Palpitations—Mycophenolic acid—systemic scleroderma	0.000192	0.00159	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Lisinopril—systemic scleroderma	0.000191	0.00159	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000191	0.00158	CcSEcCtD
Sodium stibogluconate—Vomiting—Pentoxifylline—systemic scleroderma	0.000189	0.00157	CcSEcCtD
Sodium stibogluconate—Convulsion—Mycophenolic acid—systemic scleroderma	0.000188	0.00156	CcSEcCtD
Sodium stibogluconate—Rash—Pentoxifylline—systemic scleroderma	0.000187	0.00156	CcSEcCtD
Sodium stibogluconate—Dermatitis—Pentoxifylline—systemic scleroderma	0.000187	0.00155	CcSEcCtD
Sodium stibogluconate—Headache—Pentoxifylline—systemic scleroderma	0.000186	0.00155	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000186	0.00154	CcSEcCtD
Sodium stibogluconate—Chest pain—Mycophenolic acid—systemic scleroderma	0.000185	0.00153	CcSEcCtD
Sodium stibogluconate—Infection—Leflunomide—systemic scleroderma	0.000184	0.00153	CcSEcCtD
Sodium stibogluconate—Vision blurred—Lisinopril—systemic scleroderma	0.000184	0.00153	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Captopril—systemic scleroderma	0.000184	0.00153	CcSEcCtD
Sodium stibogluconate—Anxiety—Mycophenolic acid—systemic scleroderma	0.000184	0.00153	CcSEcCtD
Sodium stibogluconate—Asthenia—Mometasone—systemic scleroderma	0.000184	0.00153	CcSEcCtD
Sodium stibogluconate—Irritability—Prednisone—systemic scleroderma	0.000184	0.00153	CcSEcCtD
Sodium stibogluconate—Hypotension—Azathioprine—systemic scleroderma	0.000184	0.00152	CcSEcCtD
Sodium stibogluconate—Pruritus—Mometasone—systemic scleroderma	0.000181	0.00151	CcSEcCtD
Sodium stibogluconate—Tachycardia—Leflunomide—systemic scleroderma	0.000181	0.0015	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000179	0.00149	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Captopril—systemic scleroderma	0.000178	0.00148	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Captopril—systemic scleroderma	0.000178	0.00148	CcSEcCtD
Sodium stibogluconate—Oedema—Mycophenolic acid—systemic scleroderma	0.000177	0.00147	CcSEcCtD
Sodium stibogluconate—Anorexia—Leflunomide—systemic scleroderma	0.000177	0.00147	CcSEcCtD
Sodium stibogluconate—Nausea—Pentoxifylline—systemic scleroderma	0.000177	0.00147	CcSEcCtD
Sodium stibogluconate—Infection—Mycophenolic acid—systemic scleroderma	0.000176	0.00146	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00146	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Mometasone—systemic scleroderma	0.000175	0.00146	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Prednisone—systemic scleroderma	0.000175	0.00146	CcSEcCtD
Sodium stibogluconate—Syncope—Lisinopril—systemic scleroderma	0.000175	0.00145	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Methotrexate—systemic scleroderma	0.000174	0.00145	CcSEcCtD
Sodium stibogluconate—Shock—Mycophenolic acid—systemic scleroderma	0.000174	0.00145	CcSEcCtD
Sodium stibogluconate—Hypotension—Leflunomide—systemic scleroderma	0.000173	0.00144	CcSEcCtD
Sodium stibogluconate—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000173	0.00143	CcSEcCtD
Sodium stibogluconate—Palpitations—Lisinopril—systemic scleroderma	0.000173	0.00143	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Lisinopril—systemic scleroderma	0.000172	0.00143	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000171	0.00142	CcSEcCtD
Sodium stibogluconate—Anorexia—Mycophenolic acid—systemic scleroderma	0.000169	0.0014	CcSEcCtD
Sodium stibogluconate—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000169	0.0014	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Prednisone—systemic scleroderma	0.000168	0.00139	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000168	0.00139	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Leflunomide—systemic scleroderma	0.000167	0.00138	CcSEcCtD
Sodium stibogluconate—Chest pain—Lisinopril—systemic scleroderma	0.000166	0.00138	CcSEcCtD
Sodium stibogluconate—Anxiety—Lisinopril—systemic scleroderma	0.000166	0.00138	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Leflunomide—systemic scleroderma	0.000166	0.00137	CcSEcCtD
Sodium stibogluconate—Hypotension—Mycophenolic acid—systemic scleroderma	0.000165	0.00137	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000164	0.00136	CcSEcCtD
Sodium stibogluconate—Vomiting—Mometasone—systemic scleroderma	0.000163	0.00135	CcSEcCtD
Sodium stibogluconate—Sweating increased—Prednisone—systemic scleroderma	0.000162	0.00135	CcSEcCtD
Sodium stibogluconate—Rash—Mometasone—systemic scleroderma	0.000162	0.00134	CcSEcCtD
Sodium stibogluconate—Asthenia—Captopril—systemic scleroderma	0.000162	0.00134	CcSEcCtD
Sodium stibogluconate—Dermatitis—Mometasone—systemic scleroderma	0.000162	0.00134	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Leflunomide—systemic scleroderma	0.000161	0.00134	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000161	0.00133	CcSEcCtD
Sodium stibogluconate—Headache—Mometasone—systemic scleroderma	0.000161	0.00133	CcSEcCtD
Sodium stibogluconate—Fatigue—Leflunomide—systemic scleroderma	0.00016	0.00133	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00016	0.00132	CcSEcCtD
Sodium stibogluconate—Oedema—Lisinopril—systemic scleroderma	0.00016	0.00132	CcSEcCtD
Sodium stibogluconate—Pruritus—Captopril—systemic scleroderma	0.000159	0.00132	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000159	0.00132	CcSEcCtD
Sodium stibogluconate—Constipation—Leflunomide—systemic scleroderma	0.000159	0.00132	CcSEcCtD
Sodium stibogluconate—Infection—Lisinopril—systemic scleroderma	0.000158	0.00132	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000158	0.00131	CcSEcCtD
Sodium stibogluconate—Shock—Lisinopril—systemic scleroderma	0.000157	0.0013	CcSEcCtD
Sodium stibogluconate—Tachycardia—Lisinopril—systemic scleroderma	0.000156	0.00129	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Azathioprine—systemic scleroderma	0.000155	0.00129	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Azathioprine—systemic scleroderma	0.000155	0.00129	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000154	0.00128	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Captopril—systemic scleroderma	0.000154	0.00128	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000154	0.00128	CcSEcCtD
Sodium stibogluconate—Irritability—Methotrexate—systemic scleroderma	0.000154	0.00128	CcSEcCtD
Sodium stibogluconate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00127	CcSEcCtD
Sodium stibogluconate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000153	0.00127	CcSEcCtD
Sodium stibogluconate—Nausea—Mometasone—systemic scleroderma	0.000152	0.00126	CcSEcCtD
Sodium stibogluconate—Anorexia—Lisinopril—systemic scleroderma	0.000152	0.00126	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000152	0.00126	CcSEcCtD
Sodium stibogluconate—Constipation—Mycophenolic acid—systemic scleroderma	0.000151	0.00126	CcSEcCtD
Sodium stibogluconate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00126	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00125	CcSEcCtD
Sodium stibogluconate—Hypotension—Lisinopril—systemic scleroderma	0.000149	0.00124	CcSEcCtD
Sodium stibogluconate—Dizziness—Captopril—systemic scleroderma	0.000149	0.00124	CcSEcCtD
Sodium stibogluconate—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00123	CcSEcCtD
Sodium stibogluconate—Urticaria—Leflunomide—systemic scleroderma	0.000147	0.00122	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Leflunomide—systemic scleroderma	0.000147	0.00122	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Leflunomide—systemic scleroderma	0.000147	0.00122	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000146	0.00122	CcSEcCtD
Sodium stibogluconate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00121	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Prednisone—systemic scleroderma	0.000146	0.00121	CcSEcCtD
Sodium stibogluconate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000145	0.00121	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000145	0.0012	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000145	0.0012	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Lisinopril—systemic scleroderma	0.000143	0.00119	CcSEcCtD
Sodium stibogluconate—Vomiting—Captopril—systemic scleroderma	0.000143	0.00119	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Lisinopril—systemic scleroderma	0.000142	0.00118	CcSEcCtD
Sodium stibogluconate—Rash—Captopril—systemic scleroderma	0.000142	0.00118	CcSEcCtD
Sodium stibogluconate—Dermatitis—Captopril—systemic scleroderma	0.000142	0.00118	CcSEcCtD
Sodium stibogluconate—Headache—Captopril—systemic scleroderma	0.000141	0.00117	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00014	0.00116	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00014	0.00116	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00116	CcSEcCtD
Sodium stibogluconate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00116	CcSEcCtD
Sodium stibogluconate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000139	0.00115	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Lisinopril—systemic scleroderma	0.000139	0.00115	CcSEcCtD
Sodium stibogluconate—Fatigue—Lisinopril—systemic scleroderma	0.000138	0.00114	CcSEcCtD
Sodium stibogluconate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000138	0.00114	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000137	0.00114	CcSEcCtD
Sodium stibogluconate—Constipation—Lisinopril—systemic scleroderma	0.000136	0.00113	CcSEcCtD
Sodium stibogluconate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00113	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000135	0.00112	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Azathioprine—systemic scleroderma	0.000135	0.00112	CcSEcCtD
Sodium stibogluconate—Nausea—Captopril—systemic scleroderma	0.000134	0.00111	CcSEcCtD
Sodium stibogluconate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00111	CcSEcCtD
Sodium stibogluconate—Asthenia—Leflunomide—systemic scleroderma	0.000133	0.00111	CcSEcCtD
Sodium stibogluconate—Pruritus—Leflunomide—systemic scleroderma	0.000131	0.00109	CcSEcCtD
Sodium stibogluconate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00108	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00013	0.00108	CcSEcCtD
Sodium stibogluconate—Dizziness—Azathioprine—systemic scleroderma	0.00013	0.00108	CcSEcCtD
Sodium stibogluconate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000127	0.00105	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Leflunomide—systemic scleroderma	0.000127	0.00105	CcSEcCtD
Sodium stibogluconate—Urticaria—Lisinopril—systemic scleroderma	0.000127	0.00105	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Lisinopril—systemic scleroderma	0.000126	0.00105	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Lisinopril—systemic scleroderma	0.000126	0.00105	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000126	0.00104	CcSEcCtD
Sodium stibogluconate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000125	0.00104	CcSEcCtD
Sodium stibogluconate—Vomiting—Azathioprine—systemic scleroderma	0.000125	0.00104	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000125	0.00103	CcSEcCtD
Sodium stibogluconate—Rash—Azathioprine—systemic scleroderma	0.000124	0.00103	CcSEcCtD
Sodium stibogluconate—Dermatitis—Azathioprine—systemic scleroderma	0.000124	0.00103	CcSEcCtD
Sodium stibogluconate—Headache—Azathioprine—systemic scleroderma	0.000123	0.00102	CcSEcCtD
Sodium stibogluconate—Dizziness—Leflunomide—systemic scleroderma	0.000123	0.00102	CcSEcCtD
Sodium stibogluconate—Renal failure—Methotrexate—systemic scleroderma	0.000122	0.00101	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00101	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000121	0.00101	CcSEcCtD
Sodium stibogluconate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000992	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Prednisone—systemic scleroderma	0.000119	0.000989	CcSEcCtD
Sodium stibogluconate—Vomiting—Leflunomide—systemic scleroderma	0.000118	0.00098	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000118	0.000975	CcSEcCtD
Sodium stibogluconate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000117	0.000972	CcSEcCtD
Sodium stibogluconate—Rash—Leflunomide—systemic scleroderma	0.000117	0.000971	CcSEcCtD
Sodium stibogluconate—Dermatitis—Leflunomide—systemic scleroderma	0.000117	0.000971	CcSEcCtD
Sodium stibogluconate—Nausea—Azathioprine—systemic scleroderma	0.000117	0.000969	CcSEcCtD
Sodium stibogluconate—Headache—Leflunomide—systemic scleroderma	0.000116	0.000965	CcSEcCtD
Sodium stibogluconate—Asthenia—Lisinopril—systemic scleroderma	0.000114	0.00095	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000949	CcSEcCtD
Sodium stibogluconate—Pruritus—Lisinopril—systemic scleroderma	0.000113	0.000937	CcSEcCtD
Sodium stibogluconate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000113	0.000935	CcSEcCtD
Sodium stibogluconate—Rash—Mycophenolic acid—systemic scleroderma	0.000112	0.000927	CcSEcCtD
Sodium stibogluconate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000112	0.000926	CcSEcCtD
Sodium stibogluconate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000922	CcSEcCtD
Sodium stibogluconate—Headache—Mycophenolic acid—systemic scleroderma	0.000111	0.000921	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000917	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000917	CcSEcCtD
Sodium stibogluconate—Nausea—Leflunomide—systemic scleroderma	0.00011	0.000915	CcSEcCtD
Sodium stibogluconate—Vision blurred—Prednisone—systemic scleroderma	0.000109	0.000908	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Lisinopril—systemic scleroderma	0.000109	0.000906	CcSEcCtD
Sodium stibogluconate—Dizziness—Lisinopril—systemic scleroderma	0.000105	0.000875	CcSEcCtD
Sodium stibogluconate—Nausea—Mycophenolic acid—systemic scleroderma	0.000105	0.000873	CcSEcCtD
Sodium stibogluconate—Syncope—Prednisone—systemic scleroderma	0.000104	0.000864	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000855	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Prednisone—systemic scleroderma	0.000102	0.000847	CcSEcCtD
Sodium stibogluconate—Vomiting—Lisinopril—systemic scleroderma	0.000101	0.000842	CcSEcCtD
Sodium stibogluconate—Rash—Lisinopril—systemic scleroderma	0.000101	0.000835	CcSEcCtD
Sodium stibogluconate—Convulsion—Prednisone—systemic scleroderma	0.000101	0.000835	CcSEcCtD
Sodium stibogluconate—Dermatitis—Lisinopril—systemic scleroderma	0.0001	0.000834	CcSEcCtD
Sodium stibogluconate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000832	CcSEcCtD
Sodium stibogluconate—Headache—Lisinopril—systemic scleroderma	9.99e-05	0.000829	CcSEcCtD
Sodium stibogluconate—Pruritus—Mycophenolate mofetil—systemic scleroderma	9.89e-05	0.000821	CcSEcCtD
Sodium stibogluconate—Anxiety—Prednisone—systemic scleroderma	9.85e-05	0.000817	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.56e-05	0.000794	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Methotrexate—systemic scleroderma	9.5e-05	0.000788	CcSEcCtD
Sodium stibogluconate—Nausea—Lisinopril—systemic scleroderma	9.48e-05	0.000786	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Prednisone—systemic scleroderma	9.47e-05	0.000786	CcSEcCtD
Sodium stibogluconate—Oedema—Prednisone—systemic scleroderma	9.47e-05	0.000786	CcSEcCtD
Sodium stibogluconate—Infection—Prednisone—systemic scleroderma	9.41e-05	0.000781	CcSEcCtD
Sodium stibogluconate—Shock—Prednisone—systemic scleroderma	9.32e-05	0.000774	CcSEcCtD
Sodium stibogluconate—Tachycardia—Prednisone—systemic scleroderma	9.25e-05	0.000767	CcSEcCtD
Sodium stibogluconate—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.24e-05	0.000767	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Prednisone—systemic scleroderma	9.16e-05	0.00076	CcSEcCtD
Sodium stibogluconate—Vision blurred—Methotrexate—systemic scleroderma	9.14e-05	0.000759	CcSEcCtD
Sodium stibogluconate—Anorexia—Prednisone—systemic scleroderma	9.03e-05	0.000749	CcSEcCtD
Sodium stibogluconate—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.89e-05	0.000738	CcSEcCtD
Sodium stibogluconate—Rash—Mycophenolate mofetil—systemic scleroderma	8.81e-05	0.000731	CcSEcCtD
Sodium stibogluconate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.8e-05	0.000731	CcSEcCtD
Sodium stibogluconate—Headache—Mycophenolate mofetil—systemic scleroderma	8.76e-05	0.000727	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Prednisone—systemic scleroderma	8.51e-05	0.000706	CcSEcCtD
Sodium stibogluconate—Convulsion—Methotrexate—systemic scleroderma	8.41e-05	0.000698	CcSEcCtD
Sodium stibogluconate—Nausea—Mycophenolate mofetil—systemic scleroderma	8.3e-05	0.000689	CcSEcCtD
Sodium stibogluconate—Chest pain—Methotrexate—systemic scleroderma	8.26e-05	0.000685	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Prednisone—systemic scleroderma	8.24e-05	0.000684	CcSEcCtD
Sodium stibogluconate—Fatigue—Prednisone—systemic scleroderma	8.17e-05	0.000678	CcSEcCtD
Sodium stibogluconate—Constipation—Prednisone—systemic scleroderma	8.1e-05	0.000672	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Methotrexate—systemic scleroderma	7.92e-05	0.000657	CcSEcCtD
Sodium stibogluconate—Infection—Methotrexate—systemic scleroderma	7.87e-05	0.000653	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Prednisone—systemic scleroderma	7.75e-05	0.000643	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Methotrexate—systemic scleroderma	7.65e-05	0.000635	CcSEcCtD
Sodium stibogluconate—Anorexia—Methotrexate—systemic scleroderma	7.55e-05	0.000626	CcSEcCtD
Sodium stibogluconate—Urticaria—Prednisone—systemic scleroderma	7.53e-05	0.000625	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Prednisone—systemic scleroderma	7.49e-05	0.000622	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Prednisone—systemic scleroderma	7.49e-05	0.000622	CcSEcCtD
Sodium stibogluconate—Hypotension—Methotrexate—systemic scleroderma	7.4e-05	0.000614	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Methotrexate—systemic scleroderma	7.11e-05	0.00059	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Methotrexate—systemic scleroderma	7.06e-05	0.000586	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Prednisone—systemic scleroderma	6.98e-05	0.000579	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Methotrexate—systemic scleroderma	6.88e-05	0.000571	CcSEcCtD
Sodium stibogluconate—Fatigue—Methotrexate—systemic scleroderma	6.83e-05	0.000567	CcSEcCtD
Sodium stibogluconate—Asthenia—Prednisone—systemic scleroderma	6.8e-05	0.000564	CcSEcCtD
Sodium stibogluconate—Pruritus—Prednisone—systemic scleroderma	6.7e-05	0.000556	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Prednisone—systemic scleroderma	6.48e-05	0.000538	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.47e-05	0.000537	CcSEcCtD
Sodium stibogluconate—Urticaria—Methotrexate—systemic scleroderma	6.29e-05	0.000522	CcSEcCtD
Sodium stibogluconate—Dizziness—Prednisone—systemic scleroderma	6.26e-05	0.00052	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Methotrexate—systemic scleroderma	6.26e-05	0.000519	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Methotrexate—systemic scleroderma	6.26e-05	0.000519	CcSEcCtD
Sodium stibogluconate—Vomiting—Prednisone—systemic scleroderma	6.02e-05	0.0005	CcSEcCtD
Sodium stibogluconate—Rash—Prednisone—systemic scleroderma	5.97e-05	0.000496	CcSEcCtD
Sodium stibogluconate—Dermatitis—Prednisone—systemic scleroderma	5.97e-05	0.000495	CcSEcCtD
Sodium stibogluconate—Headache—Prednisone—systemic scleroderma	5.94e-05	0.000493	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Methotrexate—systemic scleroderma	5.83e-05	0.000484	CcSEcCtD
Sodium stibogluconate—Asthenia—Methotrexate—systemic scleroderma	5.68e-05	0.000471	CcSEcCtD
Sodium stibogluconate—Nausea—Prednisone—systemic scleroderma	5.63e-05	0.000467	CcSEcCtD
Sodium stibogluconate—Pruritus—Methotrexate—systemic scleroderma	5.6e-05	0.000465	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Methotrexate—systemic scleroderma	5.42e-05	0.00045	CcSEcCtD
Sodium stibogluconate—Dizziness—Methotrexate—systemic scleroderma	5.24e-05	0.000435	CcSEcCtD
Sodium stibogluconate—Vomiting—Methotrexate—systemic scleroderma	5.03e-05	0.000418	CcSEcCtD
Sodium stibogluconate—Rash—Methotrexate—systemic scleroderma	4.99e-05	0.000414	CcSEcCtD
Sodium stibogluconate—Dermatitis—Methotrexate—systemic scleroderma	4.99e-05	0.000414	CcSEcCtD
Sodium stibogluconate—Headache—Methotrexate—systemic scleroderma	4.96e-05	0.000412	CcSEcCtD
Sodium stibogluconate—Nausea—Methotrexate—systemic scleroderma	4.7e-05	0.00039	CcSEcCtD
